Peptide record

TPDB09810

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09810
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb AI4AVP dbAMP 3.0 HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSGVLGVGKKVLCGLSGLC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C87H157N23O24S2
ARNDEQHIMFPTWY
GL
1973.46
9.11
2
0
9
+2
-1.52
1.362
152.86
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.06
4
Residue Composition
number
0
A
0
R
0
N
0
D
2
C
0
E
0
Q
6
G
0
H
0
I
6
L
2
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 6 H: 0 I: 0 L: 6 K: 2 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
21 reviewed residue count
C87H157N23O24S2 sequence-only estimate (linear, free termini)
1973.46 sequence-only estimate (linear, free termini)
9.11 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-1.52 sequence-only estimate (linear, free termini)
1.362 sequence-only estimate (linear, free termini)
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
8-16 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
16-32 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
8-16 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
16-32 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
8-16 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 8 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
16-32 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiviral
8-16 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 11 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

S.enteritidis

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 12 Activity

Activity

MIC
Antiviral
16-32 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli ATCC 25922 (MIC 8-16 ug/ml), S.enteritidis (MIC 128 ug/ml), and S. aureus ATCC 29213 (MIC 16-32 ug/ml).
Evidence 13 Activity

Activity

% Hemolysis
Hemolysis
100 %
[Ref.17272268] RCH=100% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.

Target

rabbit red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Mol Cell Proteomics. 2007 May 6(5):882-894.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

100% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin | Mol Cell Proteomics | 2007
Evidence 15 Activity

Activity

(30.1±4.4)% degranulation
Toxicity
50 µg/mL
Cytotoxic
(30.1±4.4)% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin | Mol Cell Proteomics | 2007
Evidence 16 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects | Antibiotics (Basel) | 2022
Evidence 17 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.17272268] RCH=100% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.

Target

erythrocytes

Source & Reference

NA
DRAMP
Mol Cell Proteomics. 2007 May 6(5):882-894.
Evidence 18 Hemolysis

Activity

100 %
% Hemolysis
[Ref.17272268] RCH=100% against rabbit red blood cells at 50 µg/ml. RCH, red cell hemolysis.
Hemolysis

Target

rabbit red blood cells

Source & Reference

HemoPI PD_Hemolysis
Mol Cell Proteomics. 2007 May 6(5):882-894.
DRAMP4
PD_Hemolysis